Silicon Valley Capital Partners

Position in MRK — Merck & Co., Inc.

CIK 1673633 SAN JOSE, CA

Position in MRK

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$45,710

+$8,869 QoQ

Shares Held

380

+8.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Silicon Valley Capital Partners holds $14,966,250 across 12 Drug Manufacturers - General names. MRK ranks #7 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,009	$11,965,287
2	JNJ	Johnson & Johnson	9,659	$2,361,045
3	PFE	Pfizer Inc	7,397	$207,707
4	AMGN	Amgen Inc	487	$171,350
5	ABBV	AbbVie Inc.	580	$126,144
6	BMY	Bristol Myers Squibb Co	1,154	$69,990
7	MRK	Merck & Co., Inc. This page	380	$45,710
8	NVO	Novo Nordisk A S	276	$10,143

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$45,710	380	+8.6%	Shares	Sole	2026-05-19
2025-12-31	$36,841	350	-17.1%	Shares	Sole	2026-02-13
2025-09-30	$35,418	422	+160.5%	Shares	Sole	2025-11-17
2025-06-30	$12,823	162	+48.6%	Shares	Sole	2025-09-11
2025-03-31	$9,783	109	-18.0%	Shares	Sole	2025-05-28
2024-12-31	$13,230	133	-99.8%	Shares	Sole	2025-01-29
2024-09-30	$8,214,362	72,335	+14.2%	Shares	Sole	2024-10-30
2024-06-30	$7,843,101	63,353	+5.8%	Shares	Sole	2024-10-30
2024-03-31	$7,904,068	59,902	+19.2%	Shares	Sole	2024-04-29
2023-12-31	$5,478,255	50,250	+9.6%	Shares	Sole	2024-02-14
2023-09-30	$4,720,257	45,850	+48.7%	Shares	Sole	2023-11-06
2023-06-30	$3,558,512	30,839	+13.4%	Shares	Sole	2023-08-14
2023-03-31	$2,893,063	27,193	+6.6%	Shares	Sole	2023-05-10
2022-12-31	$2,831,222	25,518	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.